Regulation of gene expression of macrophage-colony stimulating factor in human fibroblasts by the acute phase response mediators interleukin (IL)-1β, tumor necrosis factor-α and IL-6  by Mantovani, Luisa et al.
1. INTRODUCTION 
The dynamic nature of the hematopoietic. system sug- 
gests a flexible and complex regulation. In recent years 
much has been learned regarding soluble factors that 
govern hematopoictic blood cell development both in 
vitro and in vivo (SW [1,2] for review). The formation 
of rnonocyces/macrophages ha  been shown to be con- 
trolled by a cytokine termed macrophage-colony 
stimulating factor (M-CSF), which in addition to its ac- 
tivity on macrophagc progenitor cells stimulates the 
function of mature mononuclear phagocytes [3-51. M- 
CSF also seems to play a role in other organ systems as 
reflected by its expression in placental tissue [B] and its 
inhibitory activity on bone formation [9]. Cellular 
sources of M-CSF include mononuclear phagocytes 
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[g-10], polymorphonuclcar phagocytes [I 11, fibroblasts 
[12-14, endothelial cells [li,lS], cpithelial cells of the 
thymes [ 171, B-lymphocytes [IS] and placental tissue 
(61. Although detectable l vels of M-C!% in the circula- 
tion suggest its constirutive synthesis [19], secretion of 
M-CSF in culture is low or even undetectable unless 
producer cells are activated. Acute ~Jhasc response 
mediators uch as IL-l,0 and TNF-r~ have been shown 
to enhance M-CSF expression in mononuclear phago- 
cytes [9] and mcsenchymal cells [l&13,15,16], sug. 
gcsting that M-CSF production can be augmented on 
demand, and that acute phase mediators arc involved in 
this process. Enhancement of steady state M-CSF pro- 
duction might be necessary insituations requiring an in- 
creased number of functionally competent macro- 
phages, e.g. in inflammatory responses. In the studies 
to be reported below we show that IL-1 6, TNF-t., and 
IL-6 elevate levels of M-CSF mRNA in fibroblasts and 
we analyze mechanisms involved in this process. 
2. MATERIALS AND METHODS 
2.1. Fibrobtast preparalion and culture 
Normal human embryonic lung fibroblasts (strain FHIOO) were 
isolated by protcolytic dispersion [20). Cells were cultured and 
passaged by methods detailed elsewhere [20], In all experiments, 
fibroblasts from passage ‘i-i2 were used. Cultures \rvere ycrfarmrd in 
LY medium supplemented with 10% low cndotoxin FCS (Boehringer, 
Mannheim, Germany), lOOpg/ml penicillin, lOO,ug/tnl streptomycin, 
I mM L-glutamine, 1 mM sodium pyruvate (Gibco Laboratories, 
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SDS-PAGE anti RP.HPLC, Entla~axin confcnf ol’ :\I1 cyfokinc 
prcparnfion invcsfipaffcd wnr c SO p@rg 0r pralcin 1% arxcsacd by fhc 
limulf~a ~~nro~b~%y~~ avq. A Full lcnplh cDNA probe for Irumim ht. 
CSF (I kb &!I-Arl t’wgmcfrt cleactl info pUC 18) was kindly provid. 
cd by Br, P. Ralph, Ccfus Corporation, Emcryvillc, CA, USA, The 
2.0 kb A/I Irnpfncnf orfhc chickcn&ffcfin gcnr was drrivcrt l’rom fhc 
pAi~plaamid (kindly provided by I)r, J. Rafiraduri, Dcpi, or 
Mcdicinc, Univcrsify or M:finr, Mninr, Cicrmany). The prubcr wcrc 
‘“Q-labeled by ramhr priming 121). The tpceilic tfcfivify was 
4-8x IO’ cpm/flg* I-(~~iriot~i~inolifiylxul~onyl)-2-~icflfyl~ipcr~~~ifie 
(H7), 12~O~tefradccaf~oylphorb~l~13-:\ccfafe (TPA), cyclahcximide 
(CMX), 2-mcrrepfacfhnf~crl, ifcfinomycin~D, trypsin, and EDTA wcrc 
purchnscd from Siyrnn Ciief~iicnlr, Munich, Cicrtiiany. 
MXSF protein present in tibroblast CM was assayed by a double 
layer agar murinc (cndotoxin resistant C3WticJ mlcc) colony assay 
ifs dcscribcd [IO]. In brief, undcrlaycrs (0.5 ml) wcrc camposcd of 
0.5% ngar (Agnr Noble, Difco Labornforica, Detroit, MI, USA) in 
lscovcs modified Dulbcccos minimum essefltinl medium (IMDM, 
Sigma) supplcfi~rnlecl wifh 2OOio FCS, L~glutaminc, penicillifi/strcp- 
fomyciff (as for fibroblast cultures), and IO-’ M 2.mcrcspfocflr;fn~~l, 
Fibroblast CM to bc assnscd for M-CSF biologic activity was added 
to the underlayers at lir% vol/vol final c&cciitrnti&, Control 
cultures rcceivcd medium alone or rh M-CSF (750 U/ml). Overlayers 
(0.5 ml) were composed of 0.3% agar in fhc same medium and coti- 
mined 5x 10J/ml bone marrow cells. Colonies derived from 
macrophage~colony fortning units (MCFU) were enumcrafcd on day 
7 after fixation and staining of whole agar cultures with cy- 
naphtylacetate-esterase (ANAE). 
2.4. RNA exrrucvion, Northern blol, und trutwriptional run-on 
USSUY 
Total cellular RNA was isolated by lysing FH 10’ cells in 
guanidinium isothiocyanate followed by recovery of RNA by ten. 
trifugation through cesium chloride [22], After deneturation at 60°C, 
RNA was electrophoresed in an agerose formaldehyde gel (I ,2%) and 
transferred to synthetic membranes (Schleicher and Scl~ucll, Dasscl, 
Germany). Filters were hybridized with labeled probe for 12-24 h at 
42°C in 50% formamide. 2 x%X, SxDenhardts, 0.1% SDS, 10% 
dextran sulfateand lOO,~g/ml salmon sperm DNA. Filters were wash- 
Cd to a stringency of 0.1 Vo SSC, 65°C for 12 min and used to expose 
Kodak Xomat-ray films with intensifying screens. To exclude in- 
complete RNA transfer in single lanes, all filters were reprobed with 
,8-actin cDNA. Alterations in levels of M-CSF tvanscripts were quan- 
titated by laser densitometry using multiple exposures of the blot and 
the ratio of M-CSF/,%actin transcripts itl ucisiimulatrd cultures was 
assigned to be the baseline levels and were assumed to have 100% ac- 
tivity. 
This ratio was compared to the ratio of experitnental cultures. The 
fold change of M-CSF mRNA from base line levels was calculated by 
multiplication of the ratio of density of M-CSF/,&actin transcripts by 
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cyfosolic ~rasfion wns uhiinctl dcr ecnfrihrg:ffion nnd rlrs mcm- 
branc Ir:fcfiarr was ~~lubilirctl In bul’fcr A confwininy loio Trifun 
S~lOO l’or I5 min af 4°C. Profcin kinarc C was rcparntcd by DEAE. 
ccllrrloxc colfmfn clfronfafograptfy atid clufion wifh 80 tnM N&l. Ali. 
qunfr of RPAE.purilicd profcin kinif%c C wcrc nxxnycd t’or cyfsxolic 
and mcmbranc acfivifyin lhr prcscncc of IO mm M&la, I mM ChCl:, 
~8 IO’ cpm (7 .“PlATP (335 cpm/nrmol; Amcrohnnr, I~rautfschweig, 
Germany) and 20 pg af histotic t-II, with or wiflioirt 8 &ml 
f,husplraticiylscrinc. After incubation at 30°C Tar IO min, pretcin 
kitiasc C activity \+‘as dcfcrmincd by subfrncfirry the :IITIOII~I of ‘V in. 
c0rporafinn info hixfone HI. 
3. RESULTS 
Passage 7-12 clnbryotlic lurtg fibroblascs cxprcss M- 
CSF transcripts BC law Icvcls. Howcvcr, 8 11 following 
induction with chc acute phase response cycokines TNF- 
(r, IL-1 ,8, or IL-6, M-CSF transcripts are easily detec- 
table in 10-20 /kg of total cycoplasmic fibroblast RNA 
(Fig. IA). Fibroblascs failed to reiease M-CSF protein 
intn their culture supernatants unless culture was per- 
formed in the presence of acute phase resc)onsc 
cytokines (Fig. lE3). An increase in transcript levels 
detected by Northern blot analysis can be due to an in- 
crease in the transcriptional rate of the respective gene, 
stabilization of previously transcribed mRNAs, or a 
combination of both mechanisms. As indicated in 
Fig. 2, TNF-rr, IL-l p, and IL-6 increased M-CSF 
mRNA stability, To examine post-transcriptional 
regulation of M-CSF expression, fibroblasts were 
cultured first in medium only or with acute phase 
response cytokines and then with accinomycin D. Cells 
were harvested at different time points (O-360 min) 
after adding actinornycin D and investigated for ac- 
cumulation of M-CSF and ,8-actin mRNA. Half-life 
(tl& of M-CSF mRNA in untreated cells was < 80 min. 
After stimulation with IL-1 ,8 stability of M-CSF 
mRNA increased (f1/2=360 min). Similarly to IL-1 ,&, 
treatment of fibroblasts with both IL-6 and TNF-a, in- 
creased M-CSF mRNA half-life to 120 min and 290 
min, respectively. In order to determine whether the 
rate of M-CSF transcription increases folIowing 
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similar results with SD not exceeding 7.5%. 
Fig 1, M-CSF expression in fibroblasts cul~urcd with IL-I 8, IL-G 
and TNF-N. Panel A SIIOWL lcvcls of M-CSF mRNA, Fibroblasts were 
exposed for 8 h to either medium only, rh IL-I ,!? (100 U/ml), rh IL.6 
(10’ U/ml) or rh TN& (IO’ U/ml), Cytoplasmic RNA (20/rg/lanc) 
was prepared and analyzed by f’ormaldehydc+garose gel elec- 
trophoresis, transferred to synthetic membranes and sequentially 
hybridized with M-CSF cDNA and b-actin cDNA. The 4,0-kb 
hybridizing band is coasistent with mRNA coding for M-CSF. ,&actin 
controls for RNA loading in single lanes (not shown). The positive 
control represents mRNA derived from TPA-activated (12 nM, 8 h) 
peripheral blood monocytes hybridized with the M-CSF-specific 
cDNA. Panel B represents densitometric graphs (mean of two in- 
dependent experiments with SD not exceeding 5%) of the same ex- 
perimeats as shown in panel A in which the data are normalized to ac- 
tin mRNA levels, Panel C shows levels of M-CSF protein present in 
fibroblast cultures (72 h) that were performed in the presence of IL-1 
,8, IL-6 and TNF.cu (concentrations as above). M-CSF biologic activi- 
ty was measured by using the murine bone marrow CFUJvl assay 
(ANAE’ colonies) as described in section 2. Control cultures were 
performed with medium or rh M-CSF (750 U/ml). The experiment 
shown represents one of three independent experiments done with 
monocyte preparatioos of various donors. All experiments gave 
Fig. 3. Panel A: nuclear run-on assay analysis of the rate of ongoing 
transcription of M-CSF and @actin in fibroblasts cultured in the 
tin transcription levels. 
presence or absence (medium only) of k-6, TNF-c~ and IL-I p (con- 
centrations as indicated in the legend to Fig. 1). Nuclei were isolated 
from untreated cultures and 3 h following stimulation by cytokines. 
The in vitro 32P~labeled RNA was hybridized to pUC vector DNA 
(vector) and to piasmidS contaifiing the human M-CSF and @actin 
cDNA inserts. Panel B represents densitometric graphs (mean of two 
independent experiments with SD not exceeding V%) of the same ex- 
periments as shown in panel A in which the data are normalized to ac- 
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d, lb-6 and .TNFe. Ceneurrcnt aamplea wcw annlyacd 
by Northern blat IC) confirm that tatnl rrunscripr levcla 
increased at the time thr tran#criptian nxJ;sIy waft pcr- 
formed (darn not shown). As indicated In Fig. 3, 
stimulation of fibreblnnts with all eytokinca in- 
vestigntcct inercassd tkc rate of transcription of MCSF, 
with It-1 fl stimulating M-CSF transcription 23=fold, 
TNFe 19-fold, and IL-6 IQ-fold by laser dcnaitometry 
of autoradiographs, To analyze whether induction of 
M-CSF transcripts by acute phase response cytakincs 
requires new protein synthesis, the effect af inhibition 
of protein synthesis on cytakirre&~cluccd M-CSF 
mRNA accumulation in fibrsblnots ~8s cxamincd using 
CHX. Interestingly, CHX induced M-CSF transcripts 
within 30 mirr (Fig. 4), while in kinetic srudics not 
shown here, enhancement of M-CSF transcripts by 
acute phase response cytskinea was not detected until 
90 min, suggesting that the M-CSF gene is controlled by 
a short-lived rcprrssor molecule. However, when cells 
were cultured initially with CHX followed by addition 
Fig. 4. Panel A: accumulation of M-CSF mRNA in fibroblasts 
cultured with IL@, IL-6 and TNF-(U in absence of new protein syn- 
thesis. Northern blot analysis (15 kg) RNA per lane) of mRNA levels 
of M-CSF (4.0 kb) and @actin (2.1 kb) in fibroblasts after initial 
culture for 30 min in the presence or absence of Cl-IX @O&ml). 
Cytokines were then added for a further 3 hrs alone with or without 
CHX (2Op(g/ml), The concentrations of cytokines used correspond to 
those described in the legend to Fig. 1. The positive control represents 
mRNA derived from TPA (12 nM, 3 h) activated peripheral blood 
monocytes hybridized with the M-CSF specific cDNA. Panel B 
represents densitometric graphs (mean of two independent ex- 
periments with SD not exceeding 7%) of the same experiments as 
shown in panel A in which the data are normalized to actin mRNA 
levels. 
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of TNF-rr and IL-A, no increase af dc~cctablc M-CSF 
mRNh lcvela was obscrvcd, d~m~r~~tr~~~n~ lrhal ft>r in- 
duction of M-CSF transcripts by rhcsc esmp0u11cla new 
protein aynrhcsis; w&s rquircd aincc the cytakinca digI 
nclr induct M-CSF gcnr: expression abavc the CHX can- 
trel. Pharbslexrrrs such BX TPA wccrc nlaa able te3 in- 
crca#c lcvrlr af MG5F mRNR in fibr~bl~~~~ after 4 h af 
culture (Fig, !I). Since TPA activates PKC and xignrl 
transduction pathwnys al TN%-a and IL-6 arc still 
pssrly undersraad, we invcstigrtted hrvolvcment of 
PKC in signaling of both eytakincs. To thin end, 
fibreblnsrs were expsscd (24 h) to high cancenfrntionrr 
of TPA (24 nM) followed by rcstimularion of cells with 
either low dose TPA (4 nM), TNF-(r or ft.6 for an ad- 
ditional 4 h. Expss~e af fibroblnsts to TPA (24 nM] 
for 24 h decreased protein kinare C netiviry by >85q@ 
a 
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Fig, 5. Panel A: effect of prolonged exposure of phorbolester TPA on 
levels of WI-CSF mRNA. Cells were pretreated with TPA (24 nM, 24 
h) washed 3 times and were then exposed to rh IL-6 (LO’ U/ml), rh 
TNF-rv (10’ U/ml), TPA (8 nM) or medium alone for an additional 
4 h, As control, fibroblasts were cultured for only 4 h with IL-6, TNF- 
(r, TPA (concentrations as above) or medium only. The positive con- 
trol represents I. “NA derived from TPA (12 nM, 8 11) activated 
peripheral blood hrlunocytes. Blots (20 gg RNA per lane) were 
hybridized sequentially with M-CSF (4.0 kb) and @actin (2.1 kbj 
specific cDNA. Panel B represents densitometric graphs (mean of two 
independent experiments with SD not exceeding 7%) of the same cx- 
periments as shown in panel A in which the data are normalized to ac- 
tin mRNA levels, 
3 BI%, nnd rs*Gxpe%urc to TaA (“) nM) Pclr 4 il stid nac 
rrimulttri: the ilrciviry eT pracein kinwxc C (tlrrta nof 
rhawn), Ax shown in Fig, 5, T13A preeultured &nd 11~~s 
PKC*deplctcd fi~r~~l~st~ continued to be srimulatctl 
with TN%-rr and It-& althou& being rcfrat‘tary to 
r~sti~~ul~~io~ with TPA. Jimilrrrly, when TNF-n or 
IL-6 atimulaced I”ibroblsxcJ; were cxpnscd co the in- 
hibitor of’ PKC HT, lcvelw of’ M4ZSF rnRNA were corn- 
pnrnblc to rhaac seen with TNF-cr or IL-6 stimulation 
a\onc (Fig, 6). tfowevcr, when culture of fibroblarts 
with TNF-cu or l,L-6 wax preccedcd by a 3 h exposure fa 
IW, P dramatic increase of M-CSF mRNh lcvcls 
(5.7~Pold and 6-fold, rexpcetivrly by drnsirometry 
nnalyxio of autoractiagrnphs) as compared to cultures 
simultaneously creared with H7 and TNF-a or It-6 was 
observed. These results xuggcrf the possibility that H7 
could be inhibiting other protein kinasen or thaf TNF-m 
and IL-6 do not utilize PKC-depcndcnt signal pathways 
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Fig. 6, Panel A: effect of inhibition of PKC on levels of M-CSF 
mRNA in fibroblnsts cultured in the presence or absence of TNF-(r 
and IL-6 (concentrations as indicated in the legend to Fig. I). 
Fibroblasts were pretreated with the PKC inhibitor isoquinoline 
sulfonamide derivative M7 (3OlrM: 3 h) washed 3 times and were then 
cultured with or without TNF-n or IL-6 for additional 4 h. In addi- 
tional experiments fibroblasts were simultaneously exposed to H7 (30 
PM) and TNF-LY or IL-6 for a period of 4 h. In experiments not shown 
fibroblasts were treated with H7 (30 ,uM) and TNF-(Y or IL-6 for 7 h 
and still failed to modulate levels of M-CSF transcripts below or 
above those obtained from ‘I h cultures with TNF-ru or IL-6 only. 
Cytoptasmic RNA (i0 ,zq per lane) was sequentially hybridized with 
M-CSF cDNA and @actin cDNA. Panel B represents densitometric 
graphs (mean of two independent experiments with SD not exceeding 
5%) of the same experiments as shown in panel A in which the data 
are normalized to actin mRNA levels. 
In the present repurr we invcsrigatc the ability of 
variaur acute phase response eyroki~lea including 
TNF-wu, IL-1 #and IL-6 to regularc N-CSF expression 
in diploid humnn fibroblasrs, In an undtirnulatcd state, 
secretion of the M-CSF pro~cin by fi~ro~l~~ts is ncgligi- 
h base-line transcription enf the M=CSF gene 
and xperiTic mRNh aucumulation ia detcecnble by 
nuelcar run-on may and Northern blot analysis, Ex- 
porurr of’ fibroblom co the 3 mute plrsse response 
eytokines resulted in dccceteble M-CSF protein in eell- 
Prcc supamcam conditioned by fibroblam. Mccha- 
nirms of nerisn of these cytokines included both 
enhancement af the rrnnrcriptional rate of the M-CSF 
gene and !ncrc~e of mRNh stabilization. If should be 
recognized, however, that serum which was used in all 
of the experiments may huve exerted some of the effects 
noted, Particularly, it can not be excluded that some cf- 
feces are indirect ones which may rcault from the in- 
teraction of cytokines with serum components. Our 
results show that the regulation of expression of M-CSF 
in fibroblasts differs from that previously reported in 
monocytes in which control of M-CSF levels takes place 
at the post-trnnscriptional level only f&10], Ongoing 
studies in our laboratory therefore address whether 
regulation of M-CSF expression is tissue-specific by 
using deletion vectors of the M-CSF promoter region. 
Since previous studies by others have shown that 
regulation of granulocyte/macrophage (GM)-CSF by 
acute phase response cytokines is independent of new 
protein synthesis [23], we determined the requirement 
for protein synthesis for induction of M-CSF mRNA 
accumulation by TNF-a and IL-G. We found that treat- 
ment of fibroblasts with the inhibitor of protein syn- 
thesis CHX (20,ug/ml) resulted in a significant enhance- 
ment of levels of M-CSF mRNA. When fibroblasts 
were precultured with CHX, subsequent culture with 
TNF-cu or IL-6 failed to augment M-CSF mRNA levels 
above leveis obtained with TNF-& or IL-6 alone. To in- 
duce M-CSF levels, TNF-cu and IL-6 may therefore 
modify a preexisting protein that binds to regulatory se- 
quences of the M-CSF gene. The transcription factor 
‘NF-x B may be a candidate molecule in this regard [24]. 
To gain insights into TN&a8 and IL-6 mediated signal 
transduction mechanisms leading to increased levels of 
M-CSF mRNA, an additional set of ejcperiments was 
performed. Phorbolester TPA which acts through the 
PKC signaling pathway markedly increased M-CSF 
mRNA leirels in fibroblasts. Kn corm&t to earlier find- 
ings demonstrating that IL-1 ,& also utilizes the PKC 
pathway to induce cytokine expression [Z’S], the ability 
of both TNF-cr and IL-6 to induce M-CSF did not re- 
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qirirc PKC rtirm&Hiun, Xr has bci?rr shcnwn WC prolan$- 
ccl cxp*a1irc of fibrahlarr~ la TPA (24 h) rexulra in 
decrilaxc of PKC activity by fnorb than I!W& in both 
cytslrrel und mcmbranc lraurions (14). In our ex- 
pcrimcnrs rc+qx)surr of fibrablnstx to TPA, that wlc7rc 
already prctretWzd with TPA for 24 h and thus dcptcred 
of EaKC, failed to mount significant levels of MGF 
transcripts, Howcrcr, TPA prctrcated fibroblarts \v;6rc’ 
nc~t resistant to subscquerrt stimulation with both TNF- 
kr and IL&, This finding was csnxistrnt with darn show- 
ing that aimullantsus treatment of fibroblaatr with 
TNF-m or IL-Q and WC inhibitor 117 failed to alter 
lrvels of M-CSF dctecrablc Following treatment of 
fibroblaxts with TNF-rr or IL-6 alone, It has previously 
been shown that stability of certain mRNA spccics im- 
p,srtctl by stability regulation xqucnccr can be abro- 
gated by PKC activation (261. Inhibition of PKC may 
thus contribute to increased mRNA stability. Further 
studies will thcrcfore be ncedcd to determine synergy of 
I-37 and TNFw’It-6 to prolong M-CSF mRNA dccny, 
In this regard it has to be considered that M-CSF 
transcripts do not contain the typical AU-rich motif in 
their 3’untranslnced region known to be involved in 
recognition and regulation of mRNA stability but con- 
tain several AU-rich stretches [27]. it has also been 
shown that PKC down-modulates expression of certain 
cytokine receptors such as TNF-(r receptors [2g]. FKC 
inhibition could thus contribute to augment ligand 
rcccptivcncss. From a physiologic standpoint our data 
on M-CSF induction by acute phase response cytokines 
suggests that monocytes may augment their own 
number and function by establishing a paracrinc loop 
involving secretion of acute phase response cytokines 
that stimulate local production of M-CSF by 
fibroblasts. Fibroblast-derived M-CSF could then turn 
on monocyte production a;ld maintain their functional 
activity. 
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